Target intelligence / Profile preview

Silicone-associated biofilm matrix

Molecular classification
Extracellular matrix, Biofilm, Biomaterial surface
01

Overview

The silicone surface and its associated biofilm matrix represent a critical therapeutic target in the prevention and treatment of medical device-related infections. Silicone is a widely used polymer in implants such as breast prostheses, catheters, and heart valves, but it is highly susceptible to microbial colonization. Once microbes adhere to the silicone surface, they secrete an extracellular polymeric substance (EPS) composed of polysaccharides, proteins, and extracellular DNA (eDNA) [Donlan, R. M. (2001). Biofilms and Device-Associated Infections. Emerging Infectious Diseases]. This matrix acts as a physical and chemical barrier, protecting the embedded microbes from the host immune system and increasing their resistance to systemic antibiotics by up to 1,000-fold [Stewart, P. S., & Costerton, J. W. (2001). Antibiotic resistance of bacteria in biofilms. The Lancet]. The presence of biofilms on silicone implants is linked to chronic inflammation and complications such as capsular contracture in breast implants [Ajdic, D., et al. (2016). Analysis of the Microbiome on Implants and in Explant Capsular Tissue. Aesthetic Surgery Journal]. Therapeutic strategies focus on modifying the silicone surface with hydrophilic or antimicrobial coatings to prevent initial attachment. Additionally, agents like Dispersin B or DNase I are being investigated to enzymatically degrade the matrix components, thereby exposing the microbes to conventional antibiotics. Targeting the biofilm matrix is essential for reducing the high failure rates and surgical revisions associated with infected medical devices.

Other names
Silicone surface/biofilm matrix on silicone implantsBiofilm matrixExtracellular polymeric substance (EPS)Silicone implant biofilmMedical device-associated biofilm
02

Mechanism of action

Inhibition of microbial adhesion to the silicone surface, enzymatic degradation of the extracellular polymeric substance (EPS) matrix, and penetration of the protective barrier to deliver antimicrobial agents to sessile cells.

03

Biological functions

Microbial adhesionBarrier functionAntimicrobial resistanceNiche construction
04

Disease associations

InfectionCapsular contractureCatheter-associated urinary tract infectionProsthetic valve endocarditis
05

Safety considerations

Antimicrobial resistanceLocal tissue toxicityHypersensitivity to coating materialsSystemic toxicity from leaching
06

Interacting drugs

Rifampin

5 more in the full profile.

07

Biomarkers

C-reactive proteinProcalcitoninBiofilm-specific antibodiesMicrobial DNA

Beyond the preview

Go deeper on Silicone-associated biofilm matrix.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Silicone-associated biofilm matrix.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call